Evaluating the Efficacy of Enzalutamide and the Development of Resistance in a Preclinical Mouse Model of Type-I Endometrial Carcinoma
doi 10.1101/2019.12.06.868182
Full Text
Open PDFAbstract
Available in full text
Date
December 12, 2019
Authors
Publisher
Cold Spring Harbor Laboratory